THE SAFETY AND EFFICACY OF TENOFOVIR DF (TDF) IN COMBINATION WITH LAMIVUDINE (3TC) AND EFAVIRENZ (EFV) IN ANTIRETROVIRAL-NAIVE PATIENTS THROUGH SEVEN YEARS

被引：0
|
作者：
Carlevari, M. [1 ]
Cassetti, I. [2 ]
Madruga, J. V. R. [3 ]
Etzel, A. [4 ]
Suleiman, J. [5 ]
Zhou, Y. [6 ]
Cheng, A. K. [6 ]
Enejosa, J. [6 ]
机构：
[1] Gilead Sci Inc, Milan, Italy
[2] Fdn Ctr Estudios Infectol, Buenos Aires, DF, Argentina
[3] Ctr Referencia & Treinamento DST AIDS, Sao Paulo, Brazil
[4] Hosp Guilherme Alvaro, Santos, Brazil
[5] Brasilmed Assistencia Med & Pesquisas, Sao Paulo, Brazil
[6] Gilead Sci Inc, Foster City, CA 94404 USA
来源：
INFECTION | 2009年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [1] The safety and efficacy of tenofovir DF (TDF) in combination with lamivudine (3TC) and efavirenz (EFV) through 5 years in antiretroviral-naive patients
    Cassetti, I.
    Madruga, J. V. R.
    Suleiman, J. M. A. H.
    Zhong, L.
    Enejosa, J.
    Cheng, A. K.
    [J]. ANTIVIRAL THERAPY, 2006, 11 (07) : L50 - L51
  • [2] The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naive HIV-1-infected patients
    Cassetti, Isabel
    Madruga, Jose Valdez R.
    Suleiman, Jamal Muhamad A. H.
    Etzel, Arnaldo
    Zhong, Lijie
    Cheng, Andrew K.
    Enejosa, Jeffrey
    [J]. HIV CLINICAL TRIALS, 2007, 8 (03): : 164 - 172
  • [3] Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe
    Swartz, J. E.
    Vandekerckhove, L.
    Ammerlaan, H.
    de Vries, A. C.
    Begovac, J.
    Bierman, W. F. W.
    Boucher, C. A. B.
    van der Ende, M. E.
    Grossman, Z.
    Kaiser, R.
    Levy, I.
    Mudrikova, T.
    Paredes, R.
    Perez-Bercoff, D.
    Pronk, M.
    Richter, C.
    Schmit, J. C.
    Vercauteren, J.
    Zazzi, M.
    Lepej, S. Zidovec
    De Luca, A.
    Wensing, A. M. J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (06) : 1850 - 1857
  • [4] Baseline genotypic analysis of treatment-naive patients taking tenofovir DF (TDF) or stavudine (d4T) in combination with lamivudine (3TC) and efavirenz (EFV)
    Miller, MD
    Margot, NA
    Waters, JM
    Harris, J
    Lu, B
    Cheng, AK
    [J]. ANTIVIRAL THERAPY, 2004, 9 (04) : U118 - U118
  • [5] Resistance analyses of virologic failure through 48 weeks among treatment-naive patients taking tenofovir DF (TDF) or Stavudine (d4T) with lamivudine (3TC) and efavirenz (EFV)
    McColl, DJ
    Margot, NA
    Tran, S
    Coakley, DF
    Cheng, AK
    Miller, MD
    [J]. ANTIVIRAL RESEARCH, 2003, 57 (03) : A40 - A40
  • [6] Switch from stavudine (d4T) to tenofovir DF (TDF) in combination with lamivudine (3TC) and efavirenz (EFV) resulted in continued virological suppression and improvement in lipoatrophy through 2 years in HIV-infected patients
    Madruga, J. V. R.
    Cassetti, I.
    Suleiman, J. M. A. H.
    Zhong, L.
    Enejosa, J.
    Cheng, A. K.
    [J]. ANTIVIRAL THERAPY, 2006, 11 (07) : L21 - L21
  • [7] The 5-year safety and efficacy of the once-daily antiretroviral-naive patient regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)
    Johnson, M.
    Lazzarin, A.
    Ribera, E.
    Weitner, L.
    Chen, S. S.
    [J]. HIV MEDICINE, 2011, 12 : 76 - 76
  • [8] Twenty-four-week efficacy and resistance profile of a zidovudine/lamivudine/tenofovir DF combination therapy in antiretroviral-naive patients
    Masquelier, B
    Neau, D
    Boucher, S
    Lavignolle-Aurillac, V
    Schrive, MH
    Recordon-Pinson, P
    Ragnaud, JM
    Fleury, H
    [J]. ANTIVIRAL THERAPY, 2005, 10 : S22 - S22
  • [9] Twenty-four-week efficacy and resistance profile of a zidovudine/lamivudine/tenofovir DF combination therapy in antiretroviral-naive patients
    Masquelier, B
    Neau, D
    Boucher, S
    Lavignolle-Aurillac, V
    Schrive, MH
    Recordon-Pinson, P
    Ragnaud, JM
    Fleury, H
    [J]. ANTIVIRAL THERAPY, 2005, 10 (04) : S22 - S22
  • [10] Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial
    Gallant, JE
    Staszewski, S
    Pozniak, AL
    DeJesus, E
    Suleiman, JMAH
    Miller, MD
    Coakley, DF
    Lu, B
    Toole, JJ
    Cheng, AK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (02): : 191 - 201
12345